# Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study

> **NCT03680781** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 40 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DEVICE:** Intermittent theta-burst stimulation (iTBS) delivered to the L-DLPFC
- **DEVICE:** Intermittent theta-burst stimulation (iTBS) delivered to the bilateral DLPFC

## Key facts

- **NCT ID:** NCT03680781
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-13
- **Primary completion:** 2024-12-02
- **Final completion:** 2024-12-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680781, "Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03680781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*